Ozempic, Wegovy, Mounjaro, Zepbound: What's the difference?

Feb. 14, 2024
There are some new names on the block for drugs like Ozempic. In Medical History Mysteries, we look at the differences in these meds and what to know about side effects so we can keep patients safe.

The drugs semaglutide and tirzepatide started as treatments for type 2 diabetes, but they've become household names in the past year because of their role in weight loss. Why are there so many brand names for these drugs, and what's the difference between them?

In this episode of Medical History Mysteries, Dr. Pam and Tom explain the differences in the medications, why Ozempic has some new competition, and what dental professionals need to know about the side effects so they can treat patients safely.

Thumbnail background image credit: Photo 305457412 © Oleschwander | Dreamstime.com

More Medical History Mysteries videos …


The Dental Economics Network brings you the best content from Dental Economics, RDH, DentistryIQ, and Perio-Implant Advisory. Subscribe to get new videos each week.

Editor’s note: This article first appeared in Clinical Insights newsletter, a publication of the Endeavor Business Media Dental Group. Read more articles and subscribe.

About the Author

Pamela Maragliano-Muniz, DMD

Pamela Maragliano-Muniz, DMD, is the chief editor of DentistryIQ and editorial co-director of Through the Loupes. Based in Salem, Massachusetts, Dr. Maragliano-Muniz began her clinical career as a dental hygienist. She went on to attend Tufts University School of Dental Medicine, where she earned her doctorate in dental medicine. She then attended the University of California, Los Angeles, School of Dental Medicine, where she became board-certified in prosthodontics. Dr. Maragliano-Muniz owns a private practice, Salem Dental Arts, and lectures on a variety of clinical topics. You may contact her at [email protected].

Related:

Pamela Maragliano-Muniz, DMD, named chief editor of DentistryIQ

About the Author

Tom Viola, RPh, CCP

With more than 30 years’ experience as a board-certified pharmacist, clinical educator, professional speaker, and published author, Tom Viola, RPh, CCP, has earned the reputation as the go-to specialist for making pharmacology practical and useful for dental teams. He is the founder of Pharmacology Declassified and is a member of the faculty of more than 10 dental professional degree programs. Viola has contributed to several professional journals and pharmacology textbooks, and currently serves as a consultant to the American Dental Association’s Council on Scientific Affairs.

Updated February 10, 2022